Virax Biolabs Group Ltd. Class A (VRAX) has released an update.
Virax Biolabs Group Ltd. has announced its 2024 Annual General Meeting on December 12, where shareholders will vote on key proposals including the appointment of auditors and re-election of directors. The meeting will also address the approval of a 2024 Equity Incentive Plan. Shareholders are encouraged to participate and vote, either in person or via proxy.
For further insights into VRAX stock, check out TipRanks’ Stock Analysis page.
